ETF Overlap Tool
Enter up to six ETFs to see how much of each is the same securities. Overlap by weight is the sum, over every holding two funds share, of the smaller of the two weights: 100% means identical portfolios, 0% means nothing in common.
Overlap by weight
57 holdings in all 2 funds| Fund | EAFG | PIEL | Positions | Holdings |
|---|---|---|---|---|
| EAFGPacer Developed Markets Cash Cows Growth Leaders ETF | — | 35% 57 shared |
101 | as of Apr 30, 2026SEC filing |
| PIELPacer International Export Leaders ETF | 35% 57 shared | — | 100 | as of Apr 30, 2026SEC filing |
Each cell: overlap by weight, and how many positions the two funds share. Equity, preferred and fund holdings are compared; cash and derivatives are not.
Held by both funds
34.7% common weight| Holding | EAFG | PIEL | Smallest |
|---|---|---|---|
| ASML Holding NV | 2.65% | 6.07% | 2.65% |
| Advantest Corp | 3.19% | 2.15% | 2.15% |
| BHP Group Ltd | 1.51% | 3.05% | 1.51% |
| Roche Holding AG | 1.33% | 4.47% | 1.33% |
| Industria de Diseno Textil SA | 1.19% | 2.87% | 1.19% |
| Anheuser-Busch InBev SA/NV | 1.11% | 2.11% | 1.11% |
| Novartis AG | 1.09% | 4.87% | 1.09% |
| AstraZeneca PLC | 1.08% | 4.56% | 1.08% |
| ATLKY | 1.19% | 0.98% | 0.98% |
| Rolls-Royce Holdings PLC | 0.91% | 2.10% | 0.91% |
| UCB SA | 0.96% | 0.84% | 0.84% |
| Cie Financiere Richemont SA | 0.83% | 1.59% | 0.83% |
| Takeda Pharmaceutical Co Ltd | 0.89% | 0.83% | 0.83% |
| ASM International NV | 2.52% | 0.75% | 0.75% |
| Argenx SE | 0.74% | 0.75% | 0.74% |
| Galderma Group AG | 0.70% | 0.77% | 0.70% |
| Prysmian SpA | 1.64% | 0.69% | 0.69% |
| Fortescue Ltd | 0.90% | 0.68% | 0.68% |
| FANUC Corp | 1.88% | 0.67% | 0.67% |
| Reckitt Benckiser Group PLC | 0.62% | 0.64% | 0.62% |
| LVMH Moet Hennessy Louis Vuitt | 0.60% | 3.47% | 0.60% |
| Alcon AG | 0.62% | 0.58% | 0.58% |
| Sanofi SA | 0.58% | 1.78% | 0.58% |
| Givaudan SA | 0.56% | 0.69% | 0.56% |
| Tenaris SA | 1.83% | 0.53% | 0.53% |
| Inpex Corp | 1.36% | 0.52% | 0.52% |
| Imperial Brands PLC | 0.57% | 0.48% | 0.48% |
| Hermes International SCA | 0.45% | 3.12% | 0.45% |
| Prosus NV | 0.43% | 1.78% | 0.43% |
| HXGBY | 0.59% | 0.43% | 0.43% |
| Sony Group Corp | 0.42% | 1.90% | 0.42% |
| Lasertec Corp | 3.35% | 0.42% | 0.42% |
| Ferrari NV | 0.41% | 1.03% | 0.41% |
| Astellas Pharma Inc | 1.42% | 0.40% | 0.40% |
| BE Semiconductor Industries NV | 2.94% | 0.39% | 0.39% |
| Novonesis Novozymes B | 0.55% | 0.39% | 0.39% |
| Geberit AG | 0.71% | 0.39% | 0.39% |
| Wartsila OYJ Abp | 1.61% | 0.39% | 0.39% |
| Dassault Systemes SE | 0.38% | 0.47% | 0.38% |
| Experian PLC | 0.38% | 0.52% | 0.38% |
| Halma PLC | 1.17% | 0.36% | 0.36% |
| Amadeus IT Group SA | 0.35% | 0.40% | 0.35% |
| CSL Ltd | 0.34% | 0.67% | 0.34% |
| SAP SE | 0.34% | 3.27% | 0.34% |
| Aristocrat Leisure Ltd | 0.39% | 0.33% | 0.33% |
| Galaxy Entertainment Group Ltd | 0.51% | 0.29% | 0.29% |
| VAT Group AG | 3.31% | 0.29% | 0.29% |
| Wolters Kluwer NV | 0.34% | 0.28% | 0.28% |
| Logitech International SA | 0.52% | 0.25% | 0.25% |
| Nexon Co Ltd | 0.44% | 0.22% | 0.22% |
| Informa PLC | 0.53% | 0.22% | 0.22% |
| Evolution AB | 0.42% | 0.21% | 0.21% |
| Sonova Holding AG | 0.43% | 0.21% | 0.21% |
| Computershare Ltd | 0.48% | 0.20% | 0.20% |
| Pro Medicus Ltd | 0.31% | 0.15% | 0.15% |
| Pearson PLC | 0.53% | 0.14% | 0.14% |
| Pandora A/S | 0.32% | 0.09% | 0.09% |
Reading overlap
Two funds with 80% overlap move together and holding both mostly doubles one exposure and both fees. Low overlap is not the same as diversification: two funds can share no holdings and still be driven by the same factor. To see what a whole portfolio owns, use the portfolio x-ray.
Holdings come from each issuer's daily file where we have one and otherwise from the fund's latest SEC filing, so the two sides of a comparison can be from different dates. The table shows each fund's date.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.